6622.HK Stock Analysis
66
Uncovered
Zhaoke Ophthalmology Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Zhaoke Ophthalmology Ltd. operates as holding company with interest in providing ophthalmic pharmaceuticals. The company is headquartered in Guangzhou, Guangdong and currently employs 268 full-time employees. The company went IPO on 2021-04-29. The Company’s products include innovative drugs and generic drugs. The firm ‘s products are mainly applied in five ophthalmic indications, including dry eye disease (DED), wet age-related macular degeneration (wAMD), diabetic macular edema (DME), myopia and glaucoma.